Discover insights from industry experts
Explore our library of insightful thought leadership and relevant healthcare industry topics
Featured Insights




Blog
Tag der seltenen Krankheiten: Feier des Fortschritts und Hoffnung für die Zukunft
28. Februar 2025
Webinar
Pioneering Progress for Rare Lives: Cell and Gene Therapy Trials in Pediatric Rare Disease Populations


White Paper
Precision medicines for neurodegenerative disorders: optimizing clinical development
15. Februar 2025
Fallstudie
Successfully delivering an ultra-rare disease clinical trial in a competitive landscape
15. Februar 2025
Fallstudie
Collaborative practices advance a rare ophthalmological disease clinical trial
15. Februar 2025
White Paper
Considerations for pediatric vaccine trials in developing countries
10. Februar 2025
White Paper
Qualified infectious disease product designation: What's to GAIN?
10. Februar 2025
Fallstudie
Navigating a dynamic study design in hepatitis B research
5. Februar 2025
Fallstudie
Successfully delivering an ultra-rare disease clinical trial in a competitive landscape
4. Februar 2025
White Paper
Recognizing the “new normal” of patient-centric clinical studies
4. Februar 2025
White Paper
A new era of the clinical trial: How immuno-oncology advances are reshaping traditional clinical development paradigms
4. Februar 2025
White Paper
Continuous innovation delivers faster, more efficient clinical trials
4. Februar 2025
Fallstudie
Innovative approaches help recruit and retain patients in a rare disease hematology study
4. Februar 2025
White Paper
Designing an optimal long-term follow- up program for gene therapies and genetically modified cell therapies
4. Februar 2025
White Paper
Optimizing clinical trials for pediatric obesity treatment
4. Februar 2025
White Paper
Incorporating the voice of patient in pediatric assent forms
4. Februar 2025
Blog